Evidence map›Paper›PMID 41221016›Full record

ArticleJCEM case reports2025

Complete Unilateral Adrenalectomy is Recommended to Prevent Residual Disease in Unilateral Primary Aldosteronism.

Satoshi Nagai, Yuichi Yoshida, Shotaro Miyamoto, Yoshinori Ozeki, Shinro Hata, Hirotaka Shibata

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Satoshi NagaiDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Oita University, Yufu City, Oita 879-5593, Japan.ORCID https://orcid.org/0009-0002-1440-4316
Yuichi YoshidaDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Oita University, Yufu City, Oita 879-5593, Japan.ORCID https://orcid.org/0000-0002-5100-3135
Shotaro MiyamotoDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Oita University, Yufu City, Oita 879-5593, Japan.ORCID https://orcid.org/0000-0002-2538-9839
Yoshinori OzekiDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Oita University, Yufu City, Oita 879-5593, Japan.
Shinro HataDepartment of Urology, Oita University, Yufu City, Oita 879-5593, Japan.
Hirotaka ShibataDepartment of Endocrinology, Metabolism, Rheumatology and Nephrology, Oita University, Yufu City, Oita 879-5593, Japan.ORCID https://orcid.org/0000-0001-6506-4820

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 55-year-old man with hypertension and hypokalemia was diagnosed with primary aldosteronism (PA). Adrenal vein sampling confirmed right-sided lateralization, and computed tomography (CT) revealed a right adrenal tumor. Complete unilateral adrenalectomy was initially planned, but due to surgical challenges associated with a retroperitoneal approach and visceral obesity, he underwent laparoscopic partial adrenalectomy, removing an adrenal tumor. However, histopathological examination showed that the lesion was CYP11B2-negative, and hypertension and elevated aldosterone levels persisted, indicating residual aldosterone-producing tissue. A follow-up CT scan confirmed complete resection of the previously identified tumor, raising concerns about microscopic or multifocal aldosterone-producing nodules. Subsequently, complete unilateral adrenalectomy of the remaining right adrenal gland was performed, resulting in normalization of aldosterone levels and well-controlled blood pressure with nifedipine (80 mg/day). Pathological examination revealed a well-demarcated nodular lesion continuous with adrenal tissue. Immunohistochemical staining for CYP11B2 was positive, confirming a right aldosterone-producing nodule. PA often involves multinodular or microscopic aldosterone-producing lesions, which partial adrenalectomy may not completely remove. This case highlights the limitations of partial adrenalectomy in unilateral PA and supports complete unilateral adrenalectomy as the preferred surgical approach to achieve complete disease resolution.

Indexed as

complete unilateral adrenalectomyCYP11B2partial adrenalectomyprimary aldosteronismunilateral primary aldosteronism

Identifiers

PMID41221016
PMCPMC12598148

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.